MODERNA INC. DL-_0001
Commented by Mario Hose on January 12th, 2022 | 10:53 CET
Trading stocks after EMA warning in focus: BioNTech, Johnson + Johnson, Moderna
On Wednesday, the German indices began with a positive sign. The German benchmark index DAX is currently quoted at a level of 16,004 points and thus around 0.04% slightly up. The companies in the second tier can also hold their ground and the MDAX last traded at 34,864 points (+0.26%), TexDAX at 3,644 points and thus 0.60% lower than the previous day. SDAX also loses and last traded at 15,969 points (-0.23%).
Read
Commented by André Will-Laudien on December 21st, 2021 | 13:54 CET
Troilus Gold, Valneva, Moderna, BioNTech - Where will these stocks be in 2022?
The winners in the 2021 investment year have undeniably been the hydrogen, lithium and vaccine stocks. They temporarily gained up to 2,000% but also corrected by more than 50% in some cases. These value developments were not always fundamentally justified. Often the assumption of future achievements was sufficient for a corresponding positive development. In the case of the vaccine manufacturers, the stock market players' fantasies were fulfilled; in the case of hydrogen, this statement was valid at least for a 3-month window at the beginning of the year. Unfortunately, the year was disappointing for most gold explorers, as the precious yellow metal was unable to capitalize on the great uncertainty since the outbreak of the pandemic with a price increase. But this could change in 2022 ad hoc!
Read
Commented by Stefan Feulner on November 19th, 2021 | 12:15 CET
Moderna, Tembo Gold, Nvidia - Running!
The Corona pandemic is currently experiencing its peak in terms of infection numbers in its fourth wave. Thanks to booster shots and the soon to be approved vaccine for children, vaccine manufacturers are profiting. As a result of the torn supply chains and the semiconductor crisis, chip manufacturers are posting record results due to sharply increased prices. Inflation combined with the current low interest rate environment is, in turn, fodder for gold companies. Profit from this cycle.
Read
Commented by André Will-Laudien on November 8th, 2021 | 12:08 CET
BioNTech, Moderna, Cardiol Therapeutics, Valneva: COVID-19, the vaccination chaos is perfect!
Now the chaos is perfect. According to studies, the preparation from BioNTech/Pfizer is one of the most effective vaccines against the coronavirus. Hundreds of millions of doses have already been administered worldwide. However, the number of COVID infections is currently through the roof. Even those who have been vaccinated twice are likely still not sufficiently protected against infection. There are also unsettling rumors from BioNTech about irregularities in the conduct of studies during the vaccine's approval. Whether it concerns thereby only "rumors" or "provable facts", the capital investors do not care for the time being. They pressed the sell button and thus sent the entire peer group Adhoc into the basement. We take a closer look at the chaos.
Read
Commented by Stefan Feulner on September 6th, 2021 | 14:25 CEST
BASF, Desert Gold, Moderna, BioNTech - Keep going, keep going!
The Delta variant is teaching the markets to be afraid. After the economy was humming in the past two quarters, disillusionment is now slowly setting in. The unexpectedly weak labor market data in the US in August demonstrated this. Outside of agriculture, only 235,000 new jobs were created compared with the forecast of 728,000 new jobs. Thus, the market's fear of an end to loose monetary policy and possible interest rate hikes should also be off the table.
Read
Commented by Stefan Feulner on August 27th, 2021 | 11:53 CEST
BioNTech, XPhyto, Moderna - Boosters for the portfolio
Globally, infection numbers are rising dramatically due to the highly contagious Delta variant. According to the RKI, 12,626 new infections were reported in Germany alone, 4,226 more than a week ago. With the incidence rising above the authoritative level of 35, greater emphasis is again being placed on the rule, vaccinated, recovered or tested. As a result, demand for PCR or rapid tests is skyrocketing. Diagnostic companies, like vaccine producers, are in for a warm cash shower.
Read
Commented by Carsten Mainitz on August 16th, 2021 | 11:20 CEST
Defence Therapeutics, Moderna, Evotec - Bet on the front-runners!
Health is our most important asset. Biotech companies that protect it save not only human lives but also reap high profits. The price development of many biotech stocks over the past few months has been breathtaking. Investors are advised to focus on the frontrunners, as the market position gained as a first mover, the leadership position in a niche or innovative solution, will enable the companies to keep their competitors at bay for a long time to come.
Read
Commented by Stefan Feulner on July 8th, 2021 | 13:18 CEST
BioNTech, Defence Therapeutics, Moderna - The wheel keeps turning
After a hesitant start, Germany is making good progress with vaccinations. Around 47.5 million people, or 57.1% of the total population, have been vaccinated at least once. The number of fully vaccinated people rises to 39.9%. Rosy prospects for the summer in the republic. But now comes the Delta variant. According to initial studies, it is more resistant to the vaccines currently on the market than other variants. Research is continuing, and new manufacturers are entering the market to participate in the billion-dollar business.
Read
Commented by Stefan Feulner on January 28th, 2021 | 10:28 CET
Software AG, Upco International, Moderna - Here's the new WhatsApp!
WhatsApp is the world's leading messenger service, with over two billion users chatting, calling and sending photos to each other. However, by announcing that it was changing its privacy policy, the Facebook subsidiary has done itself a disservice. Users are now running away in droves. Competitor Telegram gained over 25 million new users within three days, and Signal was the most downloaded app in the Apple Store. Another company is also benefiting from the WhatsApp debacle, but this one can do much more than just Messenger.
Read
Commented by Stefan Feulner on January 27th, 2021 | 08:45 CET
Plug Power, Triumph Gold, Moderna - Take position before it's too late!
The new President of the United States, Joe Biden, and his predecessor, Donald Trump, have one thing in common: building up new mountains of debt. Just in time for his inauguration, the 46th President of the United States announced a new USD 1.9 trillion aid package for the economy and consumers. At some point, the extreme increase in global government and corporate and household debt will result in a major disaster. One way out is to invest in real assets. Position yourself now, before it is too late!
Read